Oncolytic virus and checkpoint inhibitor combination therapy
AssigneeTurnstone Limited Partnership
InventorsBRIAN LICHTY, JOHN BELL
Life of this patent
Estimating the term…
Abstract
The present invention pertains to a combination for simultaneous, separate or sequential use which comprises (a) an oncolytic virus and (b) a checkpoint inhibitor and to its use for the treatment of cancer.
Claims36
A method for treating and/or preventing cancer or prolonging an anti-tumor response in a mammal in need thereof, comprising administering to the mammal an effective amount of a combination comprising (a) a replicative oncolytic rhabdovirus and (b) one or more checkpoint inhibitors.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.